BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 952 filers reported holding BAXTER INTL INC in Q1 2017. The put-call ratio across all filers is 0.64 and the average weighting 0.3%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $1,304,000 | -12.8% | 20,049 | -13.3% | 0.31% | -12.3% |
| Q4 2017 | $1,495,000 | -6.2% | 23,123 | -9.0% | 0.36% | -5.0% |
| Q3 2017 | $1,594,000 | -1.4% | 25,397 | -4.8% | 0.38% | -5.3% |
| Q2 2017 | $1,616,000 | +14.0% | 26,687 | -2.3% | 0.40% | +12.7% |
| Q1 2017 | $1,417,000 | +26.6% | 27,327 | +8.3% | 0.35% | +17.3% |
| Q4 2016 | $1,119,000 | -7.2% | 25,230 | -0.4% | 0.30% | -10.7% |
| Q3 2016 | $1,206,000 | -0.1% | 25,339 | -5.1% | 0.34% | +98.2% |
| Q2 2016 | $1,207,000 | +8.1% | 26,695 | -1.9% | 0.17% | +12.6% |
| Q1 2016 | $1,117,000 | +4.6% | 27,201 | -2.8% | 0.15% | +8.6% |
| Q4 2015 | $1,068,000 | +6.0% | 27,992 | -8.8% | 0.14% | -13.7% |
| Q3 2015 | $1,008,000 | – | 30,688 | – | 0.16% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tri Locum Partners LP | 298,721 | $23,969,000 | 8.70% |
| GENERATION INVESTMENT MANAGEMENT LLP | 17,424,560 | $1,398,147,000 | 6.24% |
| Soditic Asset Management LLP | 77,950 | $6,255,000 | 6.24% |
| Veritas Asset Management LLP | 11,110,132 | $891,477,000 | 5.32% |
| Dash Acquisitions Inc. | 84,560 | $6,785,000 | 4.74% |
| Prosight Management, LP | 121,075 | $9,715,000 | 4.49% |
| TSFG, LLC | 94,977 | $7,621,000 | 4.07% |
| CINCINNATI FINANCIAL CORP | 1,344,648 | $107,895,000 | 2.93% |
| Dundas Partners LLP | 204,535 | $19,304,000 | 2.82% |
| Unified Trust Company, N.A. | 59,491 | $4,689,000 | 2.72% |